PCCA Science is at the forefront of compounding research and development. Yi Liu, PhD, a PCCA research pharmacist, walks us through a few recent and exciting developments from the PCCA Science division.

Dylan Herr, RA/QA Development Manager at Eagle, understands that the revised USP <797> chapter for sterile compounding makes significant revisions to the old chapter. In this latest article, Dyan is happy to provide you with an overview of those changes and strategies for implementing them.

The only thing that stays the same is that everything changes. This is true even when it comes to nonsterile compounding and USP <795>. PCCA Clinical Compounding Pharmacist Matt Martin, PharmD, addresses notable changes of the new USP guidelines and provides some considerations regarding implementation.

Renee Prescott, PCCA's Director of Education and Training, gives us a run down on what to be excited about at this year's International Seminar coming up in October!

Congratulations to Megan Pasookhush, PharmD, MBA, RPh, FAARFM, of Wellness Compounding Pharmacy of Carey, Carey North Carolina for being our July Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

Masking the taste of active ingredients in medications is difficult. With that in mind, PCCA Senior Formulation Pharmacist Fabiana Banov explains how your pharmacy can incorporate flavoring to make an unpalatable medicine delivery into a more pleasing experience.

Periorbital hyperpigmentation is caused by various external and internal factors, which makes it very complex to treat, but PCCA's Sara Hover, RPh, FAARM, discusses treatment options unique to personalized medicine that may help compounding pharmacies treat patients with this skin disorder.

For patients looking for migraine relief, who once used the now discontinued Midrin for migraine treatment, there are compounding options from compounding pharmacies that can personalize severe headache medications. PCCA is here to talk about options that patients have, through the help of their local compounders.

Congratulations to Luke van der Rijt and Michael O'Reilly of Southcity Pharmacy, Wagga Wagga, NSW, Austraila for being our June Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

Eagle's own Dylan Herr, discusses how the sanitary conditions for sterile and non-sterile drugs at compounding facilities are regulated and how those regulations can affect you.